Literature DB >> 8789451

Deletions in Xq28 in two boys with myotubular myopathy and abnormal genital development define a new contiguous gene syndrome in a 430 kb region.

L J Hu1, J Laporte, W Kress, P Kioschis, R Siebenhaar, A Poustka, M Fardeau, A Metzenberg, E A Janssen, N Thomas, J L Mandel, N Dahl.   

Abstract

We have recently described a female patient with myotubular myopathy (MTM1) and an interstitial deletion at Xq28. Characterisation of the deletion allowed us to position the MTM1 gene to a 600 kb region between DXS304 and DXS497. In order to further restrict the region we screened for deletions in a set of 38 patients. We found two overlapping deletions in boys that in addition to MTM1 showed an unexpected abnormal genital development. As the latter phenotype is not found in the other non-deleted MTM1 patients, our observations are best explained by a contiguous gene syndrome. The deletions define a 430 kb region that contains the MTM1 gene and most likely a gene implicated in male sexual development. A high resolution physical map of this region is presented.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8789451     DOI: 10.1093/hmg/5.1.139

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  13 in total

1.  Clinical utility gene card for: Centronuclear and myotubular myopathies.

Authors:  Valérie Biancalana; Alan H Beggs; Soma Das; Heinz Jungbluth; Wolfram Kress; Ichizo Nishino; Kathryn North; Norma B Romero; Jocelyn Laporte
Journal:  Eur J Hum Genet       Date:  2012-05-23       Impact factor: 4.246

2.  Genome-wide identification of CBX2 targets: insights in the human sex development network.

Authors:  Wassim Eid; Lennart Opitz; Anna Biason-Lauber
Journal:  Mol Endocrinol       Date:  2015-01-08

3.  Genetic Screening of Iranian Patients with 46,XY Disorders of Sex Development.

Authors:  Azadeh Shojaei; Reza Ebrahimzadeh-Vesal; Ali Ahani; Maryam Razzaghy-Azar; Golnaz Khakpour; Farideh Ghazi; Javad Tavakkoly-Bazzaz
Journal:  Rep Biochem Mol Biol       Date:  2017-10

4.  Comparative mapping on the mouse X chromosome defines a myotubular myopathy equivalent region.

Authors:  B de Gouyon; A Chatterjee; A Monaco; N Quaderi; S D Brown; G E Herman
Journal:  Mamm Genome       Date:  1996-08       Impact factor: 2.957

5.  The cnm locus, a canine homologue of human autosomal forms of centronuclear myopathy, maps to chromosome 2.

Authors:  Laurent Tiret; Stéphane Blot; Jean-Louis Kessler; Hugues Gaillot; Matthew Breen; Jean-Jacques Panthier
Journal:  Hum Genet       Date:  2003-07-23       Impact factor: 4.132

6.  Computer aided screening of inhibitors to 5-α reductase type 2 for prostate cancer.

Authors:  Biplab Bhattacharjee; Usha Talambedu; Saremy Sadegh; Arvind Kumar Goyal; Veena Pande; Madhugiri Bhujangarao Nagaveni; Vijayakumari Mali Patil; Joshi Jayadev; Sushil Kumar Middha
Journal:  Bioinformation       Date:  2011-06-23

7.  Screening of MAMLD1 mutations in 70 children with 46,XY DSD: identification and functional analysis of two new mutations.

Authors:  Nicolas Kalfa; Maki Fukami; Pascal Philibert; Francoise Audran; Catherine Pienkowski; Jacques Weill; Graziella Pinto; Sylvie Manouvrier; Michel Polak; Totsumo Ogata; Charles Sultan
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

Review 8.  Centronuclear (myotubular) myopathy.

Authors:  Heinz Jungbluth; Carina Wallgren-Pettersson; Jocelyn Laporte
Journal:  Orphanet J Rare Dis       Date:  2008-09-25       Impact factor: 4.123

Review 9.  MAMLD1 (CXorf6) is a New Gene for Hypospadias.

Authors:  Tsutomu Ogata; Maki Fukami; Yuka Wada
Journal:  Clin Pediatr Endocrinol       Date:  2008-11-08

10.  Novel findings associated with MTM1 suggest a higher number of female symptomatic carriers.

Authors:  Marco Savarese; Olimpia Musumeci; Teresa Giugliano; Anna Rubegni; Chiara Fiorillo; Fabiana Fattori; Annalaura Torella; Roberta Battini; Carmelo Rodolico; Aniello Pugliese; Giulio Piluso; Lorenzo Maggi; Adele D'Amico; Claudio Bruno; Enrico Bertini; Filippo Maria Santorelli; Marina Mora; Antonio Toscano; Carlo Minetti; Vincenzo Nigro
Journal:  Neuromuscul Disord       Date:  2016-02-17       Impact factor: 4.296

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.